Table 4.
Proportions recommended for cholesterol screening* according to the British Hyperlipidaemia Association and Drugs and Therapeutics Bulletin guidelines. Percentages for 25-64 years are directly age standardised to 1991 population of England and Wales
| Men
|
Women
|
||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age 25-44 (n=128)
|
Age 45-64 (n=194)
|
Age 25-64 (n=322)
|
Age 25-44 (n=112)
|
Age 45-64 (n=207)
|
Age 25-64 (n=319)
|
||||||||||||
| No | % (95% CI) | No | % (95% CI) | No | % (95% CI) | No | % (95% CI) | No | % (95% CI) | No | % (95% CI) | ||||||
| British Hyperlipidaemia Association: | |||||||||||||||||
| First screening level | 2 | 1.6 (0.2 to 5.5) | 31 | 16.0 (10.8 to 21.2) | 33 | 7.1 (4.3 to 9.9) | 1 | 0.9 (0.0 to 4.9) | 22 | 10.6 (6.4 to 14.8) | 23 | 4.4 (2.1 to 6.7) | |||||
| Second screening level | 13 | 10.2 (5.0 to 15.4) | 37 | 19.1 (13.6 to 24.6) | 50 | 13.2 (9.5 to 16.9) | 7 | 6.3 (1.8 to 10.8) | 40 | 19.3 (13.9 to 24.7) | 47 | 11.1 (7.7 to 14.5) | |||||
| Third screening level | 69 | 53.9 (45.3 to 62.5) | 123 | 63.4 (56.6 to 70.2) | 192 | 56.7 (51.3 to 62.1) | 55 | 49.1 (39.8 to 58.4) | 128 | 61.8 (55.2 to 68.4) | 183 | 54.4 (48.9 to 59.9) | |||||
| Drugs and Therapeutics Bulletin | 14 | 10.9 (5.5 to 16.3) | 82 | 42.3 (34.3 to 48.1) | 96 | 22.2 (17.7 to 26.7) | 7 | 6.3 (1.8 to 10.8) | 46 | 22.2 (16.5 to 27.9) | 53 | 12.2 (8.6 to 15.8) | |||||
*
See table 1 for description of criteria for screening